Phase I Study of P-cadherin–targeted Radioimmunotherapy with 90Y-FF-21101 Monoclonal Antibody in Solid Tumors-Reference-Cited by-同舟云学术

Phase I Study of P-cadherin–targeted Radioimmunotherapy with 90Y-FF-21101 Monoclonal Antibody in Solid Tumors

Published:2020-08-18 Issue:22 Volume:26 Page:5830-5842
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Subbiah Vivek^ORCID,Erwin William^ORCID,Mawlawi Osama,McCoy Asa,Wages David^ORCID,Wheeler Catherine^ORCID,Gonzalez-Lepera Carlos,Liu Holly,Macapinlac Homer^ORCID,Meric-Bernstam Funda,Hong David S.^ORCID,Pant Shubham,Le Dao,Santos Elmer,Gonzalez Jose,Roszik Jason^ORCID,Suzuki Takeaki,Subach Ruth Ann,Madden Timothy,Johansen Mary^ORCID,Nomura Fumiko,Satoh Hirokazu^ORCID,Matsuura Tadashi,Kajita Masamichi,Nakamura Eri,Funase Yuichi^ORCID,Matsushima Satoshi,Ravizzini Gregory

Funder

NIHNCINCI

Cancer Prevention and Research Institute of Texas

Sheikh Khalifa Bin Zayed Al Nahyan Institute

CATS

MD Anderson Cancer Center

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hsa_circ_0023179 modulated the processes of proliferation, apoptosis, and EMT in non-small cell lung cancer cells via the miR-615-5p/CDH3 axis;Biomolecules and Biomedicine;2024-08-18

2. Reduction of the hepatic radioactivity levels of [111In]In-DOTA–labeled antibodies via cleavage of a linkage metabolized in lysosomes;Nuclear Medicine and Biology;2024-05

3. Pioneering the Way: The Revolutionary Potential of Antibody–Drug Conjugates in NSCLC;Current Treatment Options in Oncology;2024-03-23

4. Pharmacokinetics and pharmacodynamics of antibody-drug conjugates for the treatment of patients with breast cancer;Expert Opinion on Drug Metabolism & Toxicology;2024-01-12

5. Development of antibody‐drug conjugates in cancer: Overview and prospects;Cancer Communications;2023-12-30